Risk-stratification of endometrial carcinomas revisited: A combined preoperative and intraoperative scoring system for a reliable prediction of an advanced disease

Gynecologic Oncology

Volumn 137, Issue 1, 2015, Pages 23-27

  Tuomi, Taru ^a   Pasanen, Annukka ^a   Luomaranta, Anna ^a   Leminen, Arto ^a   Bützow, Ralf ^a   Loukovaara, Mikko ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Endometrial carcinoma; Lymph node metastasis; Lymphadenectomy; Risk stratification

Indexed keywords

CA 125 ANTIGEN; MEMBRANE PROTEIN; MUC16 PROTEIN, HUMAN;

ADULT; ADVANCED CANCER; AGED; AREA UNDER THE CURVE; ARTICLE; BIOCHEMICAL ANALYSIS; BLOOD CELL COUNT; BODY MASS; BOOTSTRAPPING; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; DISEASE ASSOCIATION; DISTANT METASTASIS; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CARCINOMA; FEMALE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MIDDLE AGED; PREDICTIVE VALUE; PREOPERATIVE CARE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; RISK FACTOR; RISK SCORING SYSTEM; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; THROMBOCYTOSIS; TUMOR VOLUME; VALIDATION STUDY; AGE; BLOOD; ENDOMETRIAL NEOPLASMS; METASTASIS; PATHOLOGY; PATIENT MONITORING; PROCEDURES; PROGNOSIS; RISK; SEVERITY OF ILLNESS INDEX;

AGE FACTORS; AGED; CA-125 ANTIGEN; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MEMBRANE PROTEINS; MONITORING, INTRAOPERATIVE; NEOPLASM METASTASIS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PROGNOSIS; RISK; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; THROMBOCYTOSIS;

EID: 84929939699     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2015.01.545     Document Type: Article

References (40)

1. Chan JK, Cheung MK, Huh WK, Osann K, Husain A, Teng NN, Kapp DS. Therapeutic role of lymph node resection in endometrioid corpus cancer. A study of 12, 333 patients. Cancer 2006;107:1823-30.
2. Todo Y, Kato H, Kaneuchi M, Watari H, Takeda M, Sakuragi N. Survival effect of paraaortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet 2010;375:1165-72.
3. Mahdi H, Kumar S, Al-Wahab Z, Ali-Fehmi R, Munkarah AR. Prognostic impact of lymphadenectomy in uterine serous cancer. BJOG 2013;120:384-91.
4. Benedetti Panici P, Basile S, Maneschi F, Lissoni AA, Signorelli M, Scambia G, et al. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 2008;100:1707-16.
5. ASTEC study group. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 2009;373:125-36.
6. Mariani A, Webb MJ, Keeney GL, HaddockMG, Calori G, Podratz KC. Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary. Am J Obstet Gynecol 2000; 182:1506-19.
7. Convery PA, Cantrell LA, Di Santo N, Broadwater G, Modesitt SC, Secord AA, Havrilesky LJ. Retrospective review of an intraoperative algorithm to predict lymph node metastasis in low-grade endometrial adenocarcinoma. Gynecol Oncol 2011;123:65-70.
8. Luomaranta A, Leminen A, Loukovaara M. Prediction of lymph node and distant metastasis in patients with endometrial carcinoma: a new model based on demographics, biochemical factors, and tumor histology. Gynecol Oncol 2013;129: 28-32.
9. Luomaranta A, Leminen A, Loukovaara M. Magnetic resonance imaging in the assessment of high-risk features of endometrial carcinoma: a meta-analysis. Int J Gynecol Cancer Jul 9 2014. http://dx.doi.org/10.1097/IGC.0000000000000194 (Epub ahead of print).
10. Kitajima K, Murakami K, Yamasaki E, Kaji Y, Sugimura K. Accuracy of integrated FDG-PET/contrast-enhanced CT in detecting pelvic and paraaortic lymph node metastasis in patients with uterine cancer. Eur Radiol 2009;19:1529-36.
11. Signorelli M, Guerra L, Buda A, Picchio M, Mangili G, Dell'Anna T, et al. Role of integrated FDG PET/CT in the surgicalmanagement of patients with high risk early stage endometrial cancer: detection of pelvic nodal metastases. Gynecol Oncol 2009;115: 231-5.
12. AlHilliMM, Podratz KC, Dowdy SC, Bakkum-Gamez JN, Weaver AL, McGree ME, et al. Preoperative biopsy and intraoperative tumor diameter predict lymph node dissemination in endometrial cancer. Gynecol Oncol 2013;128:294-9.
13. Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 2009;105:103-4.
14. Kairisto V, Grönroos P, Loikkanen M, Savolainen E-R, Punnonen K, Syrjälä M, et al. New Finnish reference limits for the basic blood count. Suom Laakaril 2003;58: 5147-53.
15. Bast Jr RC, Feeney M, Lazarus H, Nadler LM, Colvin RB, Knapp RC. Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest 1981;68:1331-7.
16. Kwon JS, Qiu F, Saskin R, Carey MS. Are uterine risk factors more important than nodal status in predicting survival in endometrial cancer? Obstet Gynecol 2009; 114:736-43.
17. Barrena Medel NI, Herzog TJ, Deutsch I, Burke WM, Sun X, Lewin SN, et al. Comparison of the prognostic significance of uterine factors and nodal status for endometrial cancer. Am J Obstet Gynecol 2011;204:248.e1-7.
18. Neubauer NL, Havrilesky LJ, Calingaert B, Bulusu A, BernardiniMQ, Fleming ND, et al. The role of lymphadenectomy in themanagement of preoperative grade 1 endometrial carcinoma. Gynecol Oncol 2009;112:511-6.
19. Mavromatis ID, Antonopoulos CN, Matsoukis IL, Frangos CC, Skalkidou A, Creatsas G, et al. Validity of intraoperative gross examination of myometrial invasion in patients with endometrial cancer: ameta-analysis. Acta Obstet Gynecol Scand 2012;91:779-93.
20. Antonsen SL, Jensen LN, Loft A, Berthelsen AK, Costa J, Tabor A, et al.MRI, PET/CT and ultrasound in the preoperative staging of endometrial cancer - a multicenter prospective comparative study. Gynecol Oncol 2013;128:300-8.
21. Kumar S, Medeiros F, Dowdy SC, Keeney GL, Bakkum-Gamez JN, Podratz KC, et al. A prospective assessment of the reliability of frozen section to direct intraoperative decision making in endometrial cancer. Gynecol Oncol 2012;127:525-31.
22. Stephan JM, Hansen J, Samuelson M, McDonald M, Chin Y, Bender D, et al. Intraoperative frozen section results reliably predict final pathology in endometrial cancer. Gynecol Oncol 2014;133:499-505.
23. Frumovitz M, Slomovitz BM, Singh DK, Broaddus RR, Abrams J, Sun CC, et al. Frozen section analyses as predictors of lymphatic spread in patients with early-stage uterine cancer. J Am Coll Surg 2004;199:388-93.
24. Case AS, Rocconi RP, Straughn Jr JM, Conner M, Novak L, Wang W, et al. A prospective blinded evaluation of the accuracy of frozen section for the surgical management of endometrial cancer. Obstet Gynecol 2006;108:1375-9.
25. Kumar S, Bandyopadhyay S, Semaan A, Shah JP, Mahdi H, Morris R, et al. The role of frozen section in surgical staging of low risk endometrial cancer. PLoS One 2011;6: e21912.
26. Alektiar KM, Venkatraman E, Abu-Rustum N, Barakat RR. Is endometrial carcinoma intrinsically more aggressive in elderly patients? Cancer 2003;98:2368-77.
27. Okuma K, Yamashita H, Kawana K, Nakagawa S, Oda K, Nakagawa K. Advanced age is a significant determinant of poor prognosis in patients treated with surgery plus postoperative radiotherapy for endometrial cancer. J Obstet Gynaecol Res 2010;36: 757-63.
28. Gayar OH, Robbins JR, Parikh K, LuM, Buekers T, Munkarah A, et al. Hysterectomy for uterine adenocarcinoma in the elderly: tumor characteristics, and long-term outcome. Gynecol Oncol 2011;123:71-5.
29. Vance S, Yechieli R, Cogan C, Hanna R, Munkarah A, ElshaikhMA. The prognostic significance of age in surgically staged patients with type II endometrial carcinoma. Gynecol Oncol 2012;126:16-9.
30. Gates EJ, Hirschfield L, Matthews RP, Yap OW. Body mass index as a prognostic factor in endometrioid adenocarcinoma of the endometrium. J Natl Med Assoc 2006; 98:1814-22.
31. Ko EM, Walter P, Clark L, Jackson A, Franasiak J, Bolac C, et al. The complex triad of obesity, diabetes and race in type I and II endometrial cancers: prevalence and prognostic significance. Gynecol Oncol 2014;133:28-32.
32. Njølstad TS, Engerud H, Werner HMJ, Salvesen HB, Trovik J. Preoperative anemia, leukocytosis and thrombocytosis identify aggressive endometrial carcinomas. Gynecol Oncol 2013;131:410-5.
33. Chung HH, Kim JW, Park NH, Song YS, Kang SB, Lee HP. Use of preoperative serum CA-125 levels for prediction of lymph nodemetastasis and prognosis in endometrial cancer. Acta Obstet Gynecol Scand 2006;85:1501-5.
34. Kim HS, Park CY, Lee JM, Lee JK, Cho CH, Kim SM, et al. Evaluation of serum CA-125 levels for preoperative counseling in endometrioid endometrial cancer: a multicenter study. Gynecol Oncol 2010;118:283-8.
35. Saarelainen SK, Peltonen N, Lehtimäki T, Perheentupa A, Vuento MH, Mäenpää JU. Predictive value of serum human epididymis protein 4 and cancer antigen 125 concentrations in endometrial carcinoma. Am J Obstet Gynecol 2013;209:142.e1-6.
36. Abu-RustumNR, Gomez JD, Alektiar KM, SoslowRA, Hensley ML, Leitao JrMM, et al. The incidence of isolated paraaortic nodalmetastasis in surgically staged endometrial cancer patients with negative pelvic lymph nodes. Gynecol Oncol 2009;115:236-8.
37. Chiang AJ, Yu KJ, Chao KC, Teng NNH. The incidence of isolated para-aortic nodalmetastasis in completely staged endometrial cancer patients. Gynecol Oncol 2011;121: 122-5.
38. Mariani A, Dowdy SC, ClibyWA, Gostout BS, Jones MB, Wilson TO, et al. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol 2008;109:11-8.
39. Lewin SN, Herzog TJ, Barrena Medel NI, Deutsch I, Burke WM, Sun X, et al. Comparative performance of the 2009 International Federation of Gynecology and Obstetrics' staging system for uterine corpus cancer. Obstet Gynecol 2010;116:1141-9.
40. Harrell Jr FE, Lee KL, Mark DB. Multivariable prognosticmodels: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996;15:361-87.